Roderick Wong has an estimated net worth of $556 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Milestone Pharmaceuticals Inc., Tarsus Pharmaceuticals, Inc., Stoke Therapeutics, Inc., Athira Pharma, Inc., DermTech, Inc., ROCKET PHARMACEUTICALS, INC., Avidity Biosciences, Inc., Renovacor, Inc., TELA Bio, Inc., Landos Biopharma, Inc., Orchestra BioMed Holdings, Inc., CARGO Therapeutics, Inc., ALLURION TECHNOLOGIES, INC., Kailera Therapeutics, Inc., Health Sciences Acquisitions Corp, and PENWEST PHARMACEUTICALS CO.

2019 was Roderick Wong's most active year for acquiring shares with 45 total transactions. Roderick Wong's most active month to acquire stocks was the month of October. 2025 was Roderick Wong's most active year for disposing of shares, totalling 10 transactions. Roderick Wong's most active month to dispose stocks was the month of August. 2023 saw Roderick Wong paying a total of $87,095,139.15 for 8,777,040 shares, this is the most they've acquired in one year. In 2021 Roderick Wong cashed out on 30,842,423 shares for a total of $42,814,523.00, their largest year based on trade value.